According to a study conducted by the University of Rochester Medical Center, electronic cigarettes have been found to be just as bad as conventional cigarettes for gums and teeth.
The study, as originally published in Oncotarget, is the very first study to be done in order to learn more about the effects of e-cigarettes. The study was conducted by Irfan Rahman, Ph.D. at the UR School of Medicine and Dentistry.
E-cigarettes are perceived as being much better and healthier than the traditional kind of cigarettes and have grown in popularity. The chemicals found in cigarette smoke was thought to cause all the adverse health affects, but this study has proven quite the opposite.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
When the vapors of an electronic cigarette are burned, it causes cells to release inflammatory proteins which inevitably cause damage that can lead to many oral illnesses. Depending on how heavy the usage of an e-cigarette is, will determine the extent of the damaging effects to the oral cavity and gums.
The study that was conducted involved exposing a 3-D non-smoker human gum tissue to the vapors of an e-cigarette. It was discovered that the flavoring chemicals can cause substantial damage to the cells in the mouth. It was also discovered that some flavorings could cause more damage to cells than others. Fawad Javad, part of the UR Medical Center, states that it is important to remember that electronic cigarettes still contain nicotine, which contributes to gum disease.
There is still more research that needs to be done in order to further understand the health effects of e-cigarettes.
Oncotarget is an international journal that focuses on the pathological basis of all cancers, possible targets for therapy and treatments that can improve the management of patients suffering with cancer. The journal studies the impact of programs designed to manage new therapeutic agents on the quality of life of patients as well as their satisfaction and adherence. The journal seeks out evidence of new and existing therapies in order to improve outcomes and tries to define their usage by acceptance and the uptake by patients and health care professionals. Oncotarget is also available on Dove Press.